TY  - GEN
AU  - Fu,Xiao-Yu
AU  - Tan,De-Ming
AU  - Liu,Cui-Mei
AU  - Gu,Bin
AU  - Hu,Li-Hua
AU  - Peng,Zhong-Tian
AU  - Chen,Bin
AU  - Xie,Yuan-Lin
AU  - Gong,Huan-Yu
AU  - Hu,Xiao-Xuan
AU  - Yao,Lian-Hui
AU  - Xu,Xiao-Ping
AU  - Fu,Zheng-Yuan
AU  - He,Lang-Qiu
AU  - Li,Si-Hai
AU  - Long,Yun-Zhu
AU  - Li,De-Hui
AU  - Gu,Ji-Long
AU  - Peng,Shi-Fang
TI  - Early hepatitis B viral DNA clearance predicts treatment response at week 96
SN  - 2219-2840
PY  - 2018///0516
KW  - Adenine
KW  - analogs & derivatives
KW  - Adult
KW  - Antiviral Agents
KW  - adverse effects
KW  - Area Under Curve
KW  - China
KW  - DNA, Viral
KW  - blood
KW  - Female
KW  - Guanine
KW  - Hepatitis B e Antigens
KW  - Hepatitis B virus
KW  - drug effects
KW  - Hepatitis B, Chronic
KW  - Humans
KW  - Lamivudine
KW  - therapeutic use
KW  - Male
KW  - Middle Aged
KW  - Organophosphonates
KW  - Predictive Value of Tests
KW  - Prospective Studies
KW  - ROC Curve
KW  - Telbivudine
KW  - Thymidine
KW  - Time Factors
KW  - Treatment Outcome
KW  - Viral Load
N1  - Publication Type: Journal Article; Multicenter Study; Observational Study
UR  - https://doi.org/10.3748/wjg.v23.i16.2978
ER  -